Advanced search×

Intrapartum placement of an inferior vena cava filter for a woman with hereditary antithrombin III deficiency: its role in the prevention of fatal pulmonary embolism.

J Obstet Gynaecol Res 34(1):95-9 (2008) PMID 18226138

We present a case of a pregnant woman with hereditary antithrombin III deficiency and deep vein thrombosis of the left lower extremity managed by perinatal unfractionated heparin injection with antithrombin III replacement as well as by intrapartum placement of a temporary inferior vena cava filter. A massive thrombus of the right common iliac vein occurred during the intrapartum period despite antithrombin III replacement. An inserted filter could prevent fatal pulmonary embolism in this patient. Hereditary antithrombin III deficiency increases risk of thrombosis during pregnancy. However, discussion on intrapartum management, when anticoagulants are contraindicated due to possible hemorrhage, is minimal. Our experience suggests that thrombosis can occur and develop during the intrapartum period in an antithrombin III deficient woman despite antithrombin III replacement. It may be advisable to manage deliveries with temporary inferior vena cava filters to prevent fatal pulmonary embolism.

DOI: 10.1111/j.1447-0756.2007.00708.x
Version: za2963e q8zac q8zb8 q8zc0 q8zda q8ze6 q8zf4 q8zg0

Similar articles you may find interesting…

  1. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute isc...

    Thromb Res Suppl 119(3):265-74 (2007) PMID 16674999

    We evaluated the benefit/risk ratio of different anticoagulant regimens in the prevention of VTE in patients with AIS. The MEDLINE, EMBASE, and Cochrane Library databases were searched up to January 2005. Randomized controlled trials (RCT) comparing early administration of either low...
  2. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute isc...

    Thromb Res Suppl 119(3):265-74 (2007) PMID 16674999

    Indirect comparison of low and high doses of UFH and LMWH suggests that low-dose LMWH have the best benefit/risk ratio in patients with acute ischemic stroke by decreasing the risk of both DVT and pulmonary embolism, without a clear increase in ICH or ECH....
  3. Compliance with antithrombotic guidelines.

    Manag Care 15(9):49-50, 53-60, 66 (2006) PMID 17036939

    Venous thromboembolism (VTE) remains a significant threat to public health despite the availability of effective and safe prophylactic measures and treatments. Guidelines based on randomized clinical trials are available to improve the management of thromboembolic disease. However, gaps exist betwee...